ArriVent BioPharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:AVBP Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
10 Dec 25	SellUS$12,983,320	Hillhouse Investment Management, Ltd.	Company		555,555	US$23.37

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of AVBP?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	394,477	0.826%
Individual Insiders	896,618	1.88%
VC/PE Firms	6,956,445	14.6%
Hedge Funds	8,550,006	17.9%
Institutions	30,969,996	64.8%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 36.1%.

Top Shareholders

Top 25 shareholders own 89.64% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.45%	Suvretta Capital Management, LLC	4,401,083	US$139.7m	7.19%	3.34%
8.91%	Infinitum Asset Management, LLC	4,148,923	US$131.7m	0.61%	13.25%
8.44%	Hillhouse Investment Management, Ltd.	3,929,117	US$124.7m	0%	0.57%
6.5%	OrbiMed Advisors LLC	3,027,328	US$96.1m	0%	1.51%
6.48%	FMR LLC	3,015,861	US$95.7m	-18.6%	no data
5.43%	BlackRock, Inc.	2,530,301	US$80.3m	6.64%	no data
4.71%	HBM Partners Ltd.	2,195,014	US$69.7m	0%	6.1%
4.39%	Eli Lilly Investment Consulting (Shanghai) Co., Ltd.	2,046,123	US$64.9m	0%	5.36%
4.23%	Octagon Capital Advisors LP	1,971,054	US$62.6m	0%	6.67%
4.17%	Novo Holdings A/S	1,942,142	US$61.6m	0%	0.09%
3.64%	Sofinnova Investments, Inc.	1,696,752	US$53.9m	0%	2.63%
3.28%	Vanguard Capital Management, LLC	1,528,893	US$48.5m	0%	no data
3.21%	General Catalyst Group Management, LLC	1,494,786	US$47.4m	0%	8.19%
3.05%	State Street Global Advisors, Inc.	1,421,415	US$45.1m	30.2%	no data
1.9%	Vivo Capital, LLC	885,916	US$28.1m	0%	2.47%
1.73%	Geode Capital Management, LLC	803,652	US$25.5m	6.65%	no data
1.61%	Point72 Asset Management, L.P.	748,195	US$23.7m	245%	0.04%
1.42%	HongShan Capital Advisors Limited	663,308	US$21.1m	0%	1.44%
1.14%	Robin LaChapelle	530,213	US$16.8m	0%	no data
1.13%	The Goldman Sachs Group, Inc.	525,033	US$16.7m	-23%	no data
1.07%	Pleasant Lake Partners LLC	499,990	US$15.9m	-11.6%	1.71%
1.07%	UBS Asset Management AG	497,620	US$15.8m	7.73%	no data
0.92%	Balyasny Asset Management L.P.	426,281	US$13.5m	891%	0.03%
0.91%	Millennium Management LLC	425,923	US$13.5m	51.1%	0.01%
0.85%	The MAKS Yao Trust	394,477	US$12.5m	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/06/22 16:25
End of Day Share Price	2026/06/18 00:00
Earnings	2026/03/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

ArriVent BioPharma, Inc. is covered by 16 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Kalpit Patel	B. Riley Securities, Inc.
Mayank Mamtani	B. Riley Securities, Inc.
Suranjit Mukherjee	BTIG